;PMID: 12665390
;source_file_620.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..29] = [t:0..29]
;1)section:[e:35..119] = [t:35..119]
;2)section:[e:123..154] = [t:123..153]
;3)section:[e:158..292] = [t:158..288]
;4)sentence:[e:296..446] = [t:296..446]
;5)sentence:[e:447..657] = [t:447..657]
;6)sentence:[e:658..798] = [t:658..798]
;7)sentence:[e:799..959] = [t:799..959]
;8)sentence:[e:960..1070] = [t:960..1070]
;9)sentence:[e:1071..1300] = [t:1071..1300]
;10)sentence:[e:1301..1462] = [t:1301..1462]
;11)sentence:[e:1463..1665] = [t:1463..1665]
;12)sentence:[e:1666..1806] = [t:1666..1806]
;13)section:[e:1810..1828] = [t:1810..1828]
;14)section:[e:1834..1840] = [t:1834..1840]
;15)section:[e:1846..1862] = [t:1846..1862]
;16)section:[e:1866..1911] = [t:1866..1910]
;Sentence Matching Errors
;ERROR_Section end mismatch[e:123..154][t:123..153]
;ERROR_Section end mismatch[e:158..292][t:158..288]
;ERROR_Section end mismatch[e:1866..1911][t:1866..1910]
;Token/POS Errors
;ERROR_Token in entity file but not tree[153..154] .
;ERROR_Token in entity file but not tree[261..292]
;adam_trenton@urmc.rochester.edu
;ERROR_Token in entity file but not tree[1910..1911] ]
;ERROR_POS mismatch [11..15] t:token e:CD 2003
;ERROR_Token in tree file but not entity[261..288]
;adam_trenton@urmc.rochester

;section 0 Span:0..29
;CNS Drugs. 2003;17(5):307-24.
(SEC
  (FRAG (NNP:[0..3] CNS) (NNP:[4..9] Drugs) (.:[9..10] .) (token:[11..15] 2003)
        (::[15..16] ;) (CD:[16..18] 17) (-LRB-:[18..19] -LRB-) (CD:[19..20] 5)
        (-RRB-:[20..21] -RRB-) (::[21..22] :) (CD:[22..25] 307) (::[25..26] -)
        (CD:[26..28] 24) (.:[28..29] .)))

;section 1 Span:35..119
;Fatalities associated with therapeutic use and overdose of atypical 
;antipsychotics.
;[104..118]:substance:"antipsychotics"
(SEC
  (NP-HLN
    (NP (NNS:[35..45] Fatalities))
    (VP (VBN:[46..56] associated)
      (NP (-NONE-:[56..56] *))
      (PP-CLR (IN:[57..61] with)
        (NP
          (NP
            (NP (JJ:[62..73] therapeutic) (NN:[74..77] use))
            (CC:[78..81] and)
            (NP (NN:[82..90] overdose)))
          (PP (IN:[91..93] of)
            (NP (JJ:[94..102] atypical) (NNS:[104..118] antipsychotics))))))
    (.:[118..119] .)))
;ERROR_Entity in section[104..118]:substance "antipsychotics"

;section 2 Span:123..153
;Trenton A, Currier G, Zwemer F
(SEC
  (FRAG (NNP:[123..130] Trenton) (NNP:[131..132] A) (,:[132..133] ,)
        (NNP:[134..141] Currier) (NNP:[142..143] G) (,:[143..144] ,)
        (NNP:[145..151] Zwemer) (NNP:[152..153] F)))

(ORPH .)

;section 3 Span:158..288
;Department of Psychiatry, University of Rochester School of Medicine,
;Rochester,  New York 14642, USA. adam_trenton@urmc.rochester
(SEC
  (FRAG (NNP:[158..168] Department) (IN:[169..171] of)
        (NNP:[172..182] Psychiatry) (,:[182..183] ,) (NNP:[184..194] University)
        (IN:[195..197] of) (NNP:[198..207] Rochester) (NNP:[208..214] School)
        (IN:[215..217] of) (NNP:[218..226] Medicine) (,:[226..227] ,)
        (NNP:[228..237] Rochester) (,:[237..238] ,) (NNP:[240..243] New)
        (NNP:[244..248] York) (CD:[249..254] 14642) (,:[254..255] ,)
        (NNP:[256..259] USA) (.:[259..260] .)
        (NNP:[261..288] adam_trenton@urmc.rochester)))
;ERROR_Orphan Text from Tree File[153..158] .

(ORPH .edu)

;sentence 4 Span:296..446
;Since 1989, several novel antipsychotic drugs have become available for use 
;including clozapine, risperidone, olanzapine, quetiapine and ziprasidone.
;[322..341]:substance:"antipsychotic drugs"
;[383..392]:substance:"clozapine"
;[394..405]:substance:"risperidone"
;[407..417]:substance:"olanzapine"
;[419..429]:substance:"quetiapine"
;[434..445]:substance:"ziprasidone"
(SENT
  (S
    (PP-TMP (IN:[296..301] Since)
      (NP (CD:[302..306] 1989)))
    (,:[306..307] ,)
    (NP-SBJ (JJ:[308..315] several) (JJ:[316..321] novel)
       (JJ:[322..335] antipsychotic) (NNS:[336..341] drugs))
    (VP (VBP:[342..346] have)
      (VP (VBN:[347..353] become)
        (ADJP-PRD (JJ:[354..363] available)
          (PP (IN:[364..367] for)
            (NP (NN:[368..371] use))))
        (PP (VBG:[373..382] including)
          (NP (NN:[383..392] clozapine) (,:[392..393] ,)
              (NN:[394..405] risperidone) (,:[405..406] ,)
              (NN:[407..417] olanzapine) (,:[417..418] ,)
              (NN:[419..429] quetiapine) (CC:[430..433] and)
              (NN:[434..445] ziprasidone)))))
    (.:[445..446] .)))
;ERROR_Orphan Text from Tree File[288..296] .edu

;sentence 5 Span:447..657
;These  agents represent a substantial improvement in the treatment of
;schizophrenia and  related disorders and are considered to have a favourable
;adverse effect profile  relative to traditional antipsychotics.
;[454..460]:substance:"agents"
;[642..656]:substance:"antipsychotics"
(SENT
  (S
    (NP-SBJ-1 (DT:[447..452] These) (NNS:[454..460] agents))
    (VP
      (VP (VBP:[461..470] represent)
        (NP
          (NP (DT:[471..472] a) (JJ:[473..484] substantial)
              (NN:[485..496] improvement))
          (PP (IN:[497..499] in)
            (NP
              (NP (DT:[500..503] the) (NN:[504..513] treatment))
              (PP (IN:[514..516] of)
                (NP
                  (NP (NN:[517..530] schizophrenia))
                  (CC:[531..534] and)
                  (NP (JJ:[536..543] related) (NNS:[544..553] disorders))))))))
      (CC:[554..557] and)
      (VP (VBP:[558..561] are)
        (VP (VBN:[562..572] considered)
          (S
            (NP-SBJ-1 (-NONE-:[572..572] *))
            (VP (TO:[573..575] to)
              (VP (VB:[576..580] have)
                (NP
                  (NP (DT:[581..582] a) (JJ:[583..593] favourable)
                    (NML (JJ:[594..601] adverse) (NN:[602..608] effect))
                    (NN:[609..616] profile))
                  (ADJP (JJ:[618..626] relative)
                    (PP (TO:[627..629] to)
                      (NP (JJ:[630..641] traditional)
                          (NNS:[642..656] antipsychotics)))))))))))
    (.:[656..657] .)))

;sentence 6 Span:658..798
;Nonetheless, in rare cases, people have  died as a result of taking atypical
;antipsychotic drugs at therapeutic and  supratherapeutic doses.
;[735..754]:substance:"antipsychotic drugs"
(SENT
  (S
    (ADVP (RB:[658..669] Nonetheless))
    (,:[669..670] ,)
    (PP (IN:[671..673] in)
      (NP (JJ:[674..678] rare) (NNS:[679..684] cases)))
    (,:[684..685] ,)
    (NP-SBJ (NNS:[686..692] people))
    (VP (VBP:[693..697] have)
      (VP (VBN:[699..703] died)
        (PP (IN:[704..706] as)
          (NP
            (NP (DT:[707..708] a) (NN:[709..715] result))
            (PP (IN:[716..718] of)
              (S-NOM
                (NP-SBJ (-NONE-:[718..718] *))
                (VP (VBG:[719..725] taking)
                  (NP (JJ:[726..734] atypical)
                     (JJ:[735..748] antipsychotic) (NNS:[749..754] drugs))
                  (PP (IN:[755..757] at)
                    (NP
                      (NP (JJ:[758..769] therapeutic)
                        (NML-1 (-NONE-:[769..769] *P*)))
                      (CC:[770..773] and)
                      (NP (JJ:[775..791] supratherapeutic)
                        (NML-1 (NNS:[792..797] doses))))))))))))
    (.:[797..798] .)))

;sentence 7 Span:799..959
;Toxic doses of atypical antipsychotics are highly  variable: some patients
;have died while taking therapeutic doses and others have  survived massive
;overdoses.
;[823..837]:substance:"antipsychotics"
(SENT
  (S
    (NP-SBJ
      (NP (JJ:[799..804] Toxic) (NNS:[805..810] doses))
      (PP (IN:[811..813] of)
        (NP (JJ:[814..822] atypical) (NNS:[823..837] antipsychotics))))
    (VP (VBP:[838..841] are)
      (ADJP-PRD (RB:[842..848] highly) (JJ:[850..858] variable) (::[858..859] :)
        (S-ADV
          (S
            (NP-SBJ (DT:[860..864] some) (NNS:[865..873] patients))
            (VP (VBP:[874..878] have)
              (VP (VBN:[879..883] died)
                (SBAR-ADV (IN:[884..889] while)
                  (S
                    (NP-SBJ (-NONE-:[889..889] *))
                    (VP (VBG:[890..896] taking)
                      (NP (JJ:[897..908] therapeutic) (NNS:[909..914] doses))))))))
          (CC:[915..918] and)
          (S
            (NP-SBJ (NNS:[919..925] others))
            (VP (VBP:[926..930] have)
              (VP (VBN:[932..940] survived)
                (NP (JJ:[941..948] massive) (NNS:[949..958] overdoses))))))))
    (.:[958..959] .)))

;sentence 8 Span:960..1070
;Toxicity may be increased by coingestion of other  agents, particularly drugs
;with similar metabolic pathways.
;[1011..1017]:substance:"agents"
;[1032..1037]:substance:"drugs"
(SENT
  (S
    (NP-SBJ-1 (NN:[960..968] Toxicity))
    (VP (MD:[969..972] may)
      (VP (VB:[973..975] be)
        (VP (VBN:[976..985] increased)
          (NP-1 (-NONE-:[985..985] *))
          (PP (IN:[986..988] by)
            (NP-LGS
              (NP (NN:[989..1000] coingestion))
              (NP (IN:[1001..1003] of)
                (NP
                  (NP (JJ:[1004..1009] other) (NNS:[1011..1017] agents))
                  (,:[1017..1018] ,)
                  (NP
                    (NP
                      (ADVP (RB:[1019..1031] particularly))
                      (NNS:[1032..1037] drugs))
                    (PP (IN:[1038..1042] with)
                      (NP (JJ:[1043..1050] similar) (JJ:[1051..1060] metabolic)
                          (NNS:[1061..1069] pathways)))))))))))
    (.:[1069..1070] .)))

;sentence 9 Span:1071..1300
;Atypical  antipsychotics are metabolised predominantly by cytochrome p450
;(CYP)  isoenzymes, particularly CYP1A2 (clozapine and olanzapine), CYP3A4
;(clozapine,  quetiapine and ziprasidone) and CYP2D6 (olanzapine and
;risperidone).
;[1081..1095]:substance:"antipsychotics"
;[1129..1162]:cyp450:"cytochrome p450 (CYP)  isoenzymes"
;[1177..1183]:cyp450:"CYP1A2"
;[1185..1194]:substance:"clozapine"
;[1199..1209]:substance:"olanzapine"
;[1212..1218]:cyp450:"CYP3A4"
;[1220..1229]:substance:"clozapine"
;[1232..1242]:substance:"quetiapine"
;[1247..1258]:substance:"ziprasidone"
;[1264..1270]:cyp450:"CYP2D6"
;[1272..1282]:substance:"olanzapine"
;[1287..1298]:substance:"risperidone"
(SENT
  (S
    (NP-SBJ-1 (JJ:[1071..1079] Atypical) (NNS:[1081..1095] antipsychotics))
    (VP (VBP:[1096..1099] are)
      (VP (VBN:[1100..1111] metabolised)
        (NP-1 (-NONE-:[1111..1111] *))
        (PP-MNR
          (ADVP (RB:[1112..1125] predominantly))
          (IN:[1126..1128] by)
          (NP
            (NP
              (NML
                (NML (NN:[1129..1139] cytochrome) (NN:[1140..1144] p450))
                (NML (-LRB-:[1145..1146] -LRB-) (NN:[1146..1149] CYP)
                     (-RRB-:[1149..1150] -RRB-)))
              (NNS:[1152..1162] isoenzymes))
            (,:[1162..1163] ,)
            (NP
              (ADVP (RB:[1164..1176] particularly))
              (NP (NN:[1177..1183] CYP1A2)
                (PRN (-LRB-:[1184..1185] -LRB-)
                  (NP (NN:[1185..1194] clozapine) (CC:[1195..1198] and)
                      (NN:[1199..1209] olanzapine))
                  (-RRB-:[1209..1210] -RRB-)))
              (,:[1210..1211] ,)
              (NP (NN:[1212..1218] CYP3A4)
                (PRN (-LRB-:[1219..1220] -LRB-)
                  (NP (NN:[1220..1229] clozapine) (,:[1229..1230] ,)
                      (NN:[1232..1242] quetiapine) (CC:[1243..1246] and)
                      (NN:[1247..1258] ziprasidone))
                  (-RRB-:[1258..1259] -RRB-)))
              (CC:[1260..1263] and)
              (NP (NN:[1264..1270] CYP2D6)
                (PRN (-LRB-:[1271..1272] -LRB-)
                  (NP (NN:[1272..1282] olanzapine) (CC:[1283..1286] and)
                      (NN:[1287..1298] risperidone))
                  (-RRB-:[1298..1299] -RRB-))))))))
    (.:[1299..1300] .)))

;sentence 10 Span:1301..1462
;Concurrent  prescription of other drugs that inhibit these isoenzymes may
;increase the  probability of adverse events in patients taking atypical
;antipsychotics.
;[1335..1340]:substance:"drugs"
;[1360..1370]:cyp450:"isoenzymes"
;[1447..1461]:substance:"antipsychotics"
(SENT
  (S
    (NP-SBJ
      (NP (JJ:[1301..1311] Concurrent) (NN:[1313..1325] prescription))
      (PP (IN:[1326..1328] of)
        (NP
          (NP (JJ:[1329..1334] other) (NNS:[1335..1340] drugs))
          (SBAR
            (WHNP-1 (WDT:[1341..1345] that))
            (S
              (NP-SBJ-1 (-NONE-:[1345..1345] *T*))
              (VP (VB:[1346..1353] inhibit)
                (NP (DT:[1354..1359] these) (NNS:[1360..1370] isoenzymes))))))))
    (VP (MD:[1371..1374] may)
      (VP (VB:[1375..1383] increase)
        (NP
          (NP (DT:[1384..1387] the) (NN:[1389..1400] probability))
          (PP (IN:[1401..1403] of)
            (NP (JJ:[1404..1411] adverse) (NNS:[1412..1418] events)))
          (PP-LOC (IN:[1419..1421] in)
            (NP
              (NP (NNS:[1422..1430] patients))
              (VP (VBG:[1431..1437] taking)
                (NP (JJ:[1438..1446] atypical) (NNS:[1447..1461] antipsychotics))))))))
    (.:[1461..1462] .)))

;sentence 11 Span:1463..1665
;Deaths  due to atypical antipsychotic toxicity are often related to
;cardiovascular  complications, but pulmonary, neurological, endocrine and
;gastrointestinal  complications have also caused fatalities.
;[1487..1500]:substance:"antipsychotic"
(SENT
  (S
    (S
      (NP-SBJ-2
        (NP (NNS:[1463..1469] Deaths))
        (ADJP (JJ:[1471..1474] due)
          (PP (TO:[1475..1477] to)
            (NP (JJ:[1478..1486] atypical) (JJ:[1487..1500] antipsychotic)
                (NN:[1501..1509] toxicity)))))
      (VP (VBP:[1510..1513] are)
        (VP
          (ADVP (RB:[1514..1519] often))
          (VBN:[1520..1527] related)
          (NP-2 (-NONE-:[1527..1527] *))
          (PP-CLR (TO:[1528..1530] to)
            (NP (JJ:[1531..1545] cardiovascular)
                (NNS:[1547..1560] complications))))))
    (,:[1560..1561] ,) (CC:[1562..1565] but)
    (S
      (NP-SBJ
        (NP (JJ:[1566..1575] pulmonary)
          (NML-1 (-NONE-:[1575..1575] *P*)))
        (,:[1575..1576] ,)
        (NP (JJ:[1577..1589] neurological)
          (NML-1 (-NONE-:[1589..1589] *P*)))
        (,:[1589..1590] ,)
        (NP (JJ:[1591..1600] endocrine)
          (NML-1 (-NONE-:[1600..1600] *P*)))
        (CC:[1601..1604] and)
        (NP (JJ:[1605..1621] gastrointestinal)
          (NML-1 (NNS:[1623..1636] complications))))
      (VP (VBP:[1637..1641] have)
        (ADVP (RB:[1642..1646] also))
        (VP (VBN:[1647..1653] caused)
          (NP (NNS:[1654..1664] fatalities)))))
    (.:[1664..1665] .)))

;sentence 12 Span:1666..1806
;Prevention and management of atypical  antipsychotic overdose are of
;increased clinical relevance as prescription of  these drugs increases.
;[1705..1718]:substance:"antipsychotic"
;[1790..1795]:substance:"drugs"
(SENT
  (S
    (NP-SBJ
      (NP (NN:[1666..1676] Prevention) (CC:[1677..1680] and)
          (NN:[1681..1691] management))
      (PP (IN:[1692..1694] of)
        (NP (JJ:[1695..1703] atypical) (JJ:[1705..1718] antipsychotic)
            (NN:[1719..1727] overdose))))
    (VP (VBP:[1728..1731] are)
      (PP-PRD (IN:[1732..1734] of)
        (NP (VBN:[1735..1744] increased) (JJ:[1745..1753] clinical)
            (NN:[1754..1763] relevance)))
      (PP (IN:[1764..1766] as)
        (S-NOM
          (NP-SBJ
            (NP (NN:[1767..1779] prescription))
            (PP (IN:[1780..1782] of)
              (NP (DT:[1784..1789] these) (NNS:[1790..1795] drugs))))
          (VP (VBZ:[1796..1805] increases)))))
    (.:[1805..1806] .)))

;section 13 Span:1810..1828
;Publication Types:
(SEC
  (FRAG (NNP:[1810..1821] Publication) (NNP:[1822..1827] Types)
        (::[1827..1828] :)))

;section 14 Span:1834..1840
;Review
(SEC
  (FRAG (NNP:[1834..1840] Review)))

;section 15 Span:1846..1862
;Review, Tutorial
(SEC
  (FRAG (NNP:[1846..1852] Review) (,:[1852..1853] ,) (NNP:[1854..1862] Tutorial)))

;section 16 Span:1866..1910
;PMID: 12665390 [PubMed - indexed for MEDLINE
(SEC
  (FRAG (NNP:[1866..1870] PMID) (::[1870..1871] :) (CD:[1872..1880] 12665390)
        (-LRB-:[1881..1882] -LSB-) (NNP:[1882..1888] PubMed) (::[1889..1890] -)
        (VBN:[1891..1898] indexed) (IN:[1899..1902] for)
        (NNP:[1903..1910] MEDLINE)))
;ERROR_Orphan Text from EOF Tree File[1910..EOF] ]

(ORPH -RSB-)
